Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study.


OBJECTIVE The primary objective of this retrospective study was to investigate the possibility of achieving partial remission (PR) in AS patients treated with anti-TNF-α antagonists, such as adalimumab (ADA), etanercept (ETA) and infliximab (INF), in a real clinical practice setting. Predictors of PR were also evaluated. METHODS A retrospective study was… (More)
DOI: 10.1093/rheumatology/ket249


6 Figures and Tables

Slides referencing similar topics